Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Chu Luan Nguyen
Lawrence J. Oh
Eugene Wong
Joe Wei
Michael Chilov
机构：
[1] University of Sydney,
[2] Royal North Shore Hospital,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Anti-vascular endothelial growth factor; Neovascular age-related macular degeneration; Meta-analysis; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials
    Nguyen, Chu Luan
    Oh, Lawrence J.
    Wong, Eugene
    Wei, Joe
    Chilov, Michael
    [J]. BMC OPHTHALMOLOGY, 2018, 18
  • [2] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [3] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
    Solomon, Sharon D.
    Lindsley, Kristina
    Vedula, Satyanarayana S.
    Krzystolik, Magdalena G.
    Hawkins, Barbara S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (03):
  • [4] Efficacy and safety of different agents, dosages and strategies of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials
    Zhao, Xin-Yu
    Meng, Li-Hui
    Liu, Sheng-zhi
    Chen, You-Xin
    [J]. ACTA OPHTHALMOLOGICA, 2021, 99 (07) : E1041 - E1050
  • [5] Two-year efficacy and safety of different anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: a network meta-analysis of randomized controlled trials
    Sun, Hong
    Li, Ling
    Bu, Fengjiao
    Xin, Xiu
    Yan, Jingchao
    Huang, Taomin
    [J]. EYE, 2024,
  • [6] Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration
    Ying, Gui-shuang
    Vanderbeek, Brian L.
    [J]. LANCET, 2024, 404 (10447): : 4 - 5
  • [7] Patterns of anti-vascular endothelial growth factor discontinuation in neovascular age-related macular degeneration
    Basilious, Amy
    Smuck, Bobbi
    Duncan, Julie
    Malvankar-Mehta, Monali S.
    Juncal, Verena R.
    Hooper, Phil
    Sheidow, Tom G.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (02): : e161 - e169
  • [8] Durability of anti-vascular endothelial growth factor agents in neovascular age-related macular degeneration
    Sivaprasad, Sobha
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (06): : 540 - 541
  • [9] Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
    Matonti, Frederic
    Korobelnik, Jean-Francois
    Dot, Corinne
    Gualino, Vincent
    Soler, Vincent
    Mrejen, Sarah
    Delyfer, Marie-Noelle
    Baillif, Stephanie
    Streho, Mate
    Gascon, Pierre
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [10] Influence of Vitreomacular Interface Configuration on Anti-vascular Endothelial Growth Factor Treatment for Neovascular Age-related Macular Degeneration: A Meta-analysis
    Gao, Meng
    Liu, Wu
    Liang, XiDa
    Yu, YanPin
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345